Search results for: 'polym pharmaceutical'

The plastic packaging industry is trying to increase the quality of secondary materials and introduce post consumer recycled content in new packaging to reduce plastic waste. Extended producer responsibility policies among fast-moving consumer goods companies, rising consumer awareness, and sustainability goals such as the European Union target of ...

Artificial intelligence (AI)- and machine learning (ML)-based technologies are being leveraged for materials research and are replacing experimental and simulation-based research approaches. The need to accelerate materials discovery and the desired accuracy in the properties of materials is driving researchers to seek more granular insights from ...

This edition of the Advanced Coating & Surface Technology Opportunity Engine highlights technology developments related to innovations in hybrid coatings, coating additives, nanosheets, and deinking technologies. Innovations related to fire protection coatings, nanotube-focused coatings, nanosheet fabrication, and deinking are featured in the issue...

This issue of the Nanotechnology Opportunity Engine profiles significant advancements in nanotechnology for various enhanced industrial applications. The featured innovations include Nanoencapsulation of Drugs Using Polymeric Nanoparticles, Anti-Reflective and Photocatalytic Nano Thin Film for Solar Panels, 2D Materials for Incorporation in Multi-I...

05 Feb 2021  |  North America  |  Market Research

Shifting Spotlight from Product- to Value-based Outcomes Intensifies Growth in the US Real-world Evidence IT Solutions Market

Early-stage R&D and Commercial Applications Fuel the Growth Pipeline

Infographics

×

The US healthcare industrys transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution to...

The evolving IT landscape has played a transformative role in the field of life sciences, enabling a reliance on real-world evidence (RWE) solutions. With growing competition and the demand for precision in decision-making, pharmaceutical companies, healthcare providers, and technology organizations have realized the need for real-world data (RWD) ...

25 Jul 2016  |  Europe  |  Market Research

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

Infographics

×

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

08 Sep 2016  |  Global  |  Market Research

Growth Opportunities for Healthcare Big Data—An Analysis of Global Case Studies

Big Data Initiatives Targeted at Health Prediction and Precision

Infographics

×

The healthcare industry has been a laggard in Big Data adoption as compared to other verticals and continues to battle challenges around interoperability, budget constraints, and insufficient strategic planning and change management. However, the intent to leverage the power of Big Data is evident across all industry stakeholders, including governm...